Int J Retin Vitr
AI-Assisted Fluid Volume Analysis of Treatment-Naive nAMD in the Real World
Cattaneo J, De Oliveira Figueiredo EC, Montesel A, et al
This retrospective, exploratory analysis was designed to evaluate early anatomical and functional effects of intravitreal aflibercept 8 mg in patients with neovascular age-related macular degeneration. Anatomical and functional improvements were observed after the first 3 months, with the AI-based analysis providing detailed and automated assessment of retinal changes and valuable insights into early treatment effects.
Previous Article
- • Deep Learning-Assisted Analysis of Biomarker Changes in Therapy-Resistant Neovascular Age-Related Macular Degeneration
- • Real-World Safety and Efficacy of 8 mg Aflibercept in nAMD
- • Case Report: Aflibercept for DME in Vitrectomized Eyes
- • Guideline Recommendations for Optimal Anti-VEGF Therapy in AMD
- • AI-Assisted Fluid Volume Analysis of Treatment-Naive nAMD in the Real World
- • Consecutive Monthly Loading Administrations of Aflibercept 8 Mg for Treatment-Naïve Exudative AMD
- • Outcomes of High-Dose Aflibercept in Exudative nAMD
- • PULSAR: Intravitreal Aflibercept 8 mg in nAMD
- • PHOTON: Intravitreal Aflibercept 8 mg in Diabetic Macular Edema
- • CANDELA: Aflibercept 8 mg in Patients With nAMD
